Medications

Bayer profits up 11.5 percent on new drugs

German chemical and pharmaceutical company Bayer AG said Thursday that its net profit rose 11.5 percent in the first quarter as new drugs, led by blood thinner Xarelto, boosted sales.

Medications

Babies born in withdrawal new complication in opioid cases

The expansive court case seeking to hold drugmakers responsible for the nation's opioid crisis has a new complication: How does it deal with claims covering the thousands of babies born addicted to the drugs?

Medications

As states consider taxing opioids, drugmakers push back

Facing a rising death toll from drug overdoses, state lawmakers across the country are testing a strategy to boost treatment for opioid addicts: Force drug manufacturers and their distributors to pay for it.

Diseases, Conditions, Syndromes

Q&A: Vaccines, variants and COVID-19 trends

COVID-19 hospitalizations in the United States were on the rise for weeks heading into mid-September, right as updated COVID-19 vaccines from Pfizer and Moderna started to be distributed across the country.

Health

Panel warns FDA's beleaguered tobacco unit lacks direction

The lack of clear direction and priorities at the U.S. Food and Drug Administration's tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled ...

page 38 from 40